Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

Pediatric Pulmonology

Volumn 25, Issue 2, 1998, Pages 88-92

  Wiesemann, Heinz Georg ^a   Steinkamp, Gratiana ^b   Ratjen, Felix ^a   Bauernfeind, Adolf ^c   Przyklenk, Barbara ^c   Döring, Gerd ^d   Von Der Hardt, Horst ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cystic fibrosis; Early tobramycin; Inhalation therapy; Pseudomonas aeruginosa; Randomized clinical trial

Indexed keywords

TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; LUNG INFECTION; MALE; MEDICAL NEBULIZER; NEBULIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADMINISTRATION, INHALATION; AEROSOLS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHARYNX; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SPUTUM; TOBRAMYCIN;

EID: 2642712510     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J     Document Type: Article

References (28)

1. Bauernfeind A, Bertele RM, Harms HK, Hörl G, Jungwirth R, Petermüller C, Przyklenk B, Weisslein-Pfister C. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection. 1987: 15:270-277.
2. Hoiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand Suppl. 1982; 301:33-54.
3. FitzSimmons FC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
4. Steinkamp G, Tümmler B, Gappa M, Albus A, Potel J, Döring G, von der Hardt H. Long-term tobramycin therapy in cystic fibrosis. Pediatr Pulmonol. 1989; 6:91-98.
5. Hodson ME, Penketh ARL, Battern JC. Aerosol carbenicillin and gentamycin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981; 2:1137-1139.
6. Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. J Antimicrob Chemother. 1987; 19:831-838.
7. MacLusky IB, Gold R, Corey M, Levison H. Long-Term effect of inhaled tobramycin in patients with cystic fibrosis colonised with Pseudomonas aeruginosa. Pediatr Pulmonol. 1989; 7:42-48.
8. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astely SJ, McBurnie MA, Wentz K, Smith AL. Efficacy of aerosolised tobramycin in patients with cystic fibrosis. N Engl J Med 1993; 328:1740-1746.
9. Schaad UB, Wedgwood-Krucko J, Suter S, Kraemer R. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr. 1987; 111:599-605.
10. Stead RJ, Hodson ME, Batten JC. Inhaled ceftazidime compared with gentamycin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa. Br J Dis Chest. 1987; 81:272-279.
11. Steinkamp G, Tümmler GB, Malottke R, von der Hardt H. Treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis. Arch Dis Child. 1988; 64:1022-1028.
12. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980; 28:546-556.
13. Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985; 27:619-624.
14. Levy J, Smith AL, Kenny MA, Ramsey BW, Schoenknecht FD. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: Comparison with activity in sputum. J Infect Dis. 1983; 148:1069-1076.
15. Levy J. Antibiotic activity in sputum. J Pediatr. 1986; 108:841-846.
16. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991; 338:725-726.
17. Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early Pseudomonas colonisation in cystic fibrosis. Lancet. 1985; 1:865.
18. Vazquez C, Municio M, Corera M, Gaztelurrutia L, Sojo A, Vitorio JC. Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Acta Pediatr. 1993; 82:308-309.
19. Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974; 2:101-106.
20. American Thoracic society. Standardisation of spirometry: 1987 update. Am Rev Respir Dis. 1987; 136:1285-1298.
21. Döring G, Obernesser H-J, Botzenhart K. Extracellular toxins of Pseudomonas aeruginosa. III. Radioimmunoassay for detection of alkaline protease. Zentralbl Bakteriol Mikrobiol Hyg (A). 1982; 252:239-247.
22. Obernesser H-J, Döring G. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase. Zentralbl Bakteriol Mikrobiol Hyg (A). 1982; 252:248-256.
23. Döring G, Goldstein W, Schiotz PO, Hoiby N, Botzenhart K. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun. 1985; 49:557-562.
24. Döring G, Obernesser H-J, Botzenhart K, Flehmig B, Hoiby N, Hofmann A. Proteases of Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis. 1983; 147:744-750.
25. Brett MM, Simmonds EJ, Ghoneim ATM, Littlewood JM. The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child. 1992; 67:1086-1088.
26. Döring G, Hoiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun. 1983; 42:197-201.
27. Ramsey BW, Wentz KR, Smith AL, Richardson M, Williamson-Warren J, Hedges DL, Gibson R, Redding GJ, Lent K, Harris K. Predictive value of oro-pharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis. 1991; 144:331-337.
28. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonisation with Pseudomonas aeruginosa. J Pediatr. 1990; 116: 714-719.